FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions icon

15.5.7 Resource AdministrableProductDefinition - Mappings

Biomedical Research and Regulation icon Work GroupMaturity Level: N/AStandards Status: InformativeSecurity Category: Anonymous Compartments: No defined compartments

Mappings:

FiveWs Pattern Mapping

IDMP Mapping

Mappings for the administrableproductdefinition resource (see Mappings to Other Standards for further information & status).

15.5.7.1 FiveWs Pattern Mapping (http://hl7.org/fhir/fivews icon)

AdministrableProductDefinition administrative.medication
    identifier FiveWs.class

15.5.7.2 IDMP Mapping (https://www.iso.org/obp/ui/#iso:std:iso:11615 icon)

AdministrableProductDefinition Pharmaceutical Product
    identifier PhPID
    status n/a
    formOf (link to Medicinal Product)
    administrableDoseForm Pharmaceutical Product.Administrable Dose Form
    unitOfPresentation Pharmaceutical Product.Unit of Presentation
    producedFrom n/a (this is the link from Pharmaceutical Product to the Manufactured Item(s))
    ingredient Pharmaceutical Product.Ingredient (see also FHIR Ingredient resource)
    device Pharmaceutical Product.Device
    description n/a
    property Pharmaceutical Product Characteristics
        type Pharmaceutical Product Characteristics.Code System (not a one to one map, the resource is more capable)
        value[x] Pharmaceutical Product Characteristics.Value (not a one to one map, the resource is more capable)
        status Pharmaceutical Product Characteristics.Status
    routeOfAdministration Pharmaceutical Product.Route of Administration
        code Route of Administration.Route of Administration
        firstDose Dosing and Route of Administration.First dose in humans (Investigational Medicinal Product)
        maxSingleDose Dosing and Route of Administration.Maximum single dose (Investigational Medicinal Product)
        maxDosePerDay Dosing and Route of Administration.Maximum dose per day (Investigational Medicinal Product)
        maxDosePerTreatmentPeriod Dosing and Route of Administration.Maximum dose per treatment period (Investigational Medicinal Product)
        maxTreatmentPeriod Dosing and Route of Administration.Maximum treatment period (Investigational Medicinal Product)
        targetSpecies n/a
            code n/a
            withdrawalPeriod n/a
                tissue n/a
                value n/a
                supportingInformation n/a